Iida SI, Hirota T, Morisaki T, Marumoto T, Hara T, Kuninaka S, Honda S, Kosai K, Kawasuji M, Pallas DC, Saya H.

Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G(1) tetraploidy checkpoint function.

Oncogene. 23: 5266-5274, 2004

Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H.

Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.

Circulation. 109; 2572-2580, 2004

Hisaka Y, Ieda M, Nakamura T, Kosai K, Ogawa S, Fukuda K.

Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase.

J Am Coll Cardiol. 43:1915-22, 2004

Nagano S, Yuge K, Fukunaga M, Terazaki Y, Fujiwara H, Komiya S, Kosai K.

Gene Therapy eradicating distant disseminated micro-metastases by optimal cytokine expression in the primary lesion only -novel concepts for successful cytokine gene therapy.

Int. J. Oncol. 24: 549-558, 2004

Ikoma T, Takahashi T, Nagano S, Li Y-M, Ohno Y, Ando K, Fujiwara T, Fujiwara H and Kosai K.

A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.

Clin Cancer Res. 10; 1192-1200, 2004

Tsuneoka M, Umata T, Kimura H, Koda Y, Nakajima M, Kosai K, Takahashi T, Takahashi Y, Yamamoto A.

c-myc induces autophagy in rat 3Y1 fibroblast cells.

Cell Struct Funct. 28: 195-204, 2003

Li Y, Takemura G, Kosai K, Yuge K, Nagano S, Esaki M, Goto K, Takahashi T, Hayakawa K, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Mizuguchi H, Fujiwara T, Fujiwara H.

Postinfarct treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.

Circulation. 107: 2499-2506, 2003

Himeno W, Akagi T, Furui A, Maeno Y, Ishii M, Kosai K, Murohara T, Kato H.

Increased angiogenic growth factor in cyanotic congenital heart disease.

Pediatr Cardiol, 24: 127-32. 2003

Terazaki Y, Yano S, Yuge K, Nagano S, Fukunaga M, Guo ZS, Komiya S, Shirouzu K, Kosai, K.

An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice.

Hepatology 37:155-163. 2003

Mitsui K, Tokuzawa Y, Segawa K, Murakami M, Itoh H, Takahashi K, Maeda M, Yamanaka S.

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

Cell 113 631-642. 2003